CATEGORIES: Featured | Research

Become a Certified CMT-FOM Clinical Evaluator at the HNF Clinical Trial Readiness Summit

by | Feb 27, 2025 | 0 comments

Become a Certified CMT-FOM Clinical Evaluator at the HNF Clinical Trial Readiness Summit

The Hereditary Neuropathy Foundation (HNF) is proud to offer an exclusive opportunity to become one of the first Fully Certified CMT-FOM Clinical Evaluators at the upcoming HNF Clinical Trial Readiness Summit in Nashville, TN. This groundbreaking training will take place from April 23-26, 2025.

This is a unique and FREE training opportunity led by Dr. Joshua Burns, PhD, at St. Jude Children’s Research Hospital and Dr. Kayla Cornett, PhD, at the University of Sydney designed for clinical professionals seeking to enhance their expertise in the Charcot-Marie-Tooth disease (CMT) Functional Outcome Measure (CMT-FOM). However, participants must cover their own travel expenses to Nashville.

Why Get Fully Certified?

Upon successful completion of this program, participants will receive Full Certification, granting them:

  • Membership of the inaugural group of Certified CMT Clinical Evaluators, listed on ClinicalOutcomeMeasures.org
  • Access to ongoing training, quality assurance, and advanced online knowledge resources
  • Exclusive Q&A sessions with Master Trainers
  • Eligibility to become a Master Trainer
  • Inclusion in a global community of practice with fellow Clinical Evaluators
  • Limited Spots Available – Register ASAP!

Limited Spots Available – Register ASAP!

Space is limited, so interested candidates should register as soon as possible to secure their spot.

For more information or to register, contact us at [email protected]

Why is CMT Clinical Training More Important Than Ever?

The landscape of CMT research and clinical trials is evolving rapidly, with new therapeutic approaches emerging and more clinical trials than ever before. The ability to accurately assess functional outcomes in individuals with CMT is critical to the success of these trials. With the growing adoption of wearable technologies, digital biomarkers, and advanced clinical measures, properly trained evaluators are in high demand to ensure the reliability of trial data. By becoming fully certified, clinical professionals will be equipped with the latest skills and expertise needed to drive forward groundbreaking treatments and accelerate the pathway to a cure.

Learn more on this topic

Related Blog Posts

Hot off the press

It seems like almost weekly there is another new publication on CMT with interesting basic biology. While an earlier “Hot off the press” highlighted the work of Cherry and co-workers at the University of Texas Southwestern Medical Center who showed show that neurons lacking a gene for rab7 result in neuropathy.

New Study on CMT Type 2B

If we are to learn more about CMT and the effectiveness of rehabilitation it is worth asking the patient and their caregiver. A recent Italian study by Padua et al recently described a survey of CMT patients and caregivers and their perspectives and perceptions of rehabilitation efficacy and needs.

Allison Moore is going to be published!

HNF’s CSO (Chief Scientific Officer), Sean Ekins wrote a blog about his work with Allison Moore and her two “fighter Mom” friends Lori Sames and Jill Wood. He named his blog: “Rare disease heroes – Extraordinary collaborators we should be listening too.” Sean helped my friends and I write a paper called: “Multifaceted roles of ultra rare and rare disease patients/parents in drug discovery.” YES, Allison Moore is going to be published! It will be in Drug Discovery Today, soon. The link to the reprint is below.

HNF and Wave Skater form a Partnership

I (Allison Moore)  is amazed how life moves in such wondrous ways. My family has the good fortune to spend summers at a beautiful Long Island beach where my husband and boys enjoy riding the waves on boogie boards.

HNF-WVU-NIOSH Study update:

We are pleased to update our readers on the progress of the WVU-NIOSH study, “A Bi-Directional Translational Model of Exercise Training in the Treatment of Charcot-Marie-Tooth Disease”

Join the conversation

Leave a Comment

0 Comments

Submit a Comment

Your email address will not be published. Required fields are marked *

Newsletter

Join for notifications on events, campaigns, & news